Arkolith/Insider Trading/STOK/Form 4

Tzianabos Arthur

Interim Executive Chair, DirectorStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Mar 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$174K
Net Open-Market Flow
-$174K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)4K$40.00$174K31K
Mar 10, 2026Option exercise(M)4K$8.33$33K36K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2026Option exercise(M)4K—$0119K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001586226-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML